CN111909048B - 一种多组分一锅法合成阿托伐他汀钙中间体的方法 - Google Patents
一种多组分一锅法合成阿托伐他汀钙中间体的方法 Download PDFInfo
- Publication number
- CN111909048B CN111909048B CN202010926970.XA CN202010926970A CN111909048B CN 111909048 B CN111909048 B CN 111909048B CN 202010926970 A CN202010926970 A CN 202010926970A CN 111909048 B CN111909048 B CN 111909048B
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- catalyst
- formula
- recited
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
- C07C239/18—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
- B01J31/1805—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
- C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
- C07D273/04—Six-membered rings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/30—Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
- B01J2231/32—Addition reactions to C=C or C-C triple bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/824—Palladium
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (9)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010926970.XA CN111909048B (zh) | 2020-09-07 | 2020-09-07 | 一种多组分一锅法合成阿托伐他汀钙中间体的方法 |
EP20886173.2A EP3984991A4 (en) | 2020-09-07 | 2020-11-18 | METHOD FOR SYNTHESIZING A CALCIUM INTERMEDIATE OF ATORVASTATIN USING A MULTI-COMPONENT MONOTOPE PROCESS |
PCT/CN2020/129673 WO2022048025A1 (zh) | 2020-09-07 | 2020-11-18 | 一种多组分一锅法合成阿托伐他汀钙中间体的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010926970.XA CN111909048B (zh) | 2020-09-07 | 2020-09-07 | 一种多组分一锅法合成阿托伐他汀钙中间体的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111909048A CN111909048A (zh) | 2020-11-10 |
CN111909048B true CN111909048B (zh) | 2021-03-16 |
Family
ID=73267506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010926970.XA Active CN111909048B (zh) | 2020-09-07 | 2020-09-07 | 一种多组分一锅法合成阿托伐他汀钙中间体的方法 |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3984991A4 (zh) |
CN (1) | CN111909048B (zh) |
WO (1) | WO2022048025A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114195670B (zh) * | 2021-12-31 | 2024-03-15 | 河南豫辰药业股份有限公司 | 一种阿托伐他汀母核m4的精制方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989007598A2 (en) * | 1988-02-22 | 1989-08-24 | Warner-Lambert Company | Improved process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
WO2007029217A1 (en) * | 2005-09-09 | 2007-03-15 | Pfizer Science And Technology Ireland Limited | Preparation of an atorvastatin intermediate |
WO2009019561A2 (en) * | 2007-08-03 | 2009-02-12 | Pfizer Products Inc. | Process for preparing chiral compounds |
CN101805279A (zh) * | 2010-01-22 | 2010-08-18 | 绍兴民生医药有限公司 | 阿托伐他汀钙的制备方法 |
WO2012143933A1 (en) * | 2011-04-21 | 2012-10-26 | Vijayasri Organics Limited | A PROCESS FOR PREPARATION OF 4-FLUORO-α-[2-METHYL-L-OXOPROPYL]-γ-OXO-N-β-DIPHENYLBENZENE BUTANE AMIDE |
CN108218759A (zh) * | 2018-01-12 | 2018-06-29 | 天方药业有限公司 | 一种阿托伐他汀钙制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002057229A1 (en) * | 2001-01-19 | 2002-07-25 | Biocon India Limited | FORM V CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-ß,$G(D)-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1- HEPTANOIC ACID HEMI CALCIUM SALT. (ATORVASTATIN) |
US20080280970A1 (en) * | 2007-05-08 | 2008-11-13 | Czarnik Anthony W | Deuterium-enriched atorvastatin |
-
2020
- 2020-09-07 CN CN202010926970.XA patent/CN111909048B/zh active Active
- 2020-11-18 EP EP20886173.2A patent/EP3984991A4/en active Pending
- 2020-11-18 WO PCT/CN2020/129673 patent/WO2022048025A1/zh unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989007598A2 (en) * | 1988-02-22 | 1989-08-24 | Warner-Lambert Company | Improved process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
WO2007029217A1 (en) * | 2005-09-09 | 2007-03-15 | Pfizer Science And Technology Ireland Limited | Preparation of an atorvastatin intermediate |
WO2009019561A2 (en) * | 2007-08-03 | 2009-02-12 | Pfizer Products Inc. | Process for preparing chiral compounds |
CN101805279A (zh) * | 2010-01-22 | 2010-08-18 | 绍兴民生医药有限公司 | 阿托伐他汀钙的制备方法 |
WO2012143933A1 (en) * | 2011-04-21 | 2012-10-26 | Vijayasri Organics Limited | A PROCESS FOR PREPARATION OF 4-FLUORO-α-[2-METHYL-L-OXOPROPYL]-γ-OXO-N-β-DIPHENYLBENZENE BUTANE AMIDE |
CN108218759A (zh) * | 2018-01-12 | 2018-06-29 | 天方药业有限公司 | 一种阿托伐他汀钙制备方法 |
Non-Patent Citations (2)
Title |
---|
The total synthesis of calcium atorvastatin†;Luiz C. Dias等;《Organic & Biomolecular Chemistry》;20161231;第14卷(第7期);2291-2296 * |
阿托伐他汀钙中间体的合成工艺研究;饶历等;《武汉工程大学学报》;20101231;第32卷(第12期);10-12 * |
Also Published As
Publication number | Publication date |
---|---|
WO2022048025A1 (zh) | 2022-03-10 |
EP3984991A4 (en) | 2022-10-12 |
EP3984991A1 (en) | 2022-04-20 |
CN111909048A (zh) | 2020-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | Enol-functionalized N-heterocyclic carbene lanthanide amide complexes: Synthesis, molecular structures and catalytic activity for addition of amines to carbodiimides | |
Tu et al. | Bridged bis (amidinate) lanthanide aryloxides: syntheses, structures, and catalytic activity for addition of amines to carbodiimides | |
EP2539321A1 (en) | Saxagliptin intermediates, saxagliptin polymorphs, and processes for preparation thereof | |
CN111909048B (zh) | 一种多组分一锅法合成阿托伐他汀钙中间体的方法 | |
CN103113293B (zh) | 多取代喹啉衍生物及其制备方法 | |
Vériot et al. | Synthesis of C3-cyclotriveratrylene ligands for iron (II) and iron (III) coordination | |
CN111440151A (zh) | 制备抗肿瘤药普拉赛替尼的方法 | |
CN106866525A (zh) | 用于合成(1r,2s)‑贝达喹啉的手性诱导剂 | |
CN108218798B (zh) | Apabetalone的制备方法 | |
US10100055B2 (en) | Imidazopyrroloquinoline salt, method for producing the same, medicament, cosmetic, and food | |
CN101333437A (zh) | 炔基连接的卟啉类近红外荧光化合物及制备方法 | |
CN113444057B (zh) | 单手性臂氨基酚磺酰胺配体及在不对称催化中的应用 | |
CN109251175A (zh) | 嘧啶酮类化合物的制备方法 | |
CN110256441A (zh) | 一种巴瑞克替尼的制备方法 | |
CN112876376B (zh) | 一种烯丙基芳基类化合物的合成方法 | |
CN114773385B (zh) | 一种含双膦邻位碳硼烷二价铜配合物及其制备与应用 | |
Zhao et al. | Synthesis, crystal structures and properties of 1, 1′-ferrocenyldi (bisamide) derivatives generated by the double Ugi four-component reaction | |
EP2540717B1 (en) | Lamivudine oxalate and preparation method thereof | |
Dindar et al. | Reductive N-methylation of alkanolamines with paraformaldehyde in the presence of cobalt catalysts | |
CN108558878B (zh) | 一种喹叨啉及其衍生物的合成工艺 | |
JP4223601B2 (ja) | 新規ジピリルメテン化合物及びその製造方法 | |
Polak et al. | Silyl‐Substituted ortho‐Terphenoxide Group 3–5 Complexes: Synthesis, Structure and Applications in Catalysis | |
CN111138420A (zh) | 一种c13同位素标记的拉帕替尼合成方法 | |
JP3845719B2 (ja) | メソ−置換ポルフイリン誘導体化合物の製造方法 | |
CN116804026A (zh) | 一种壳聚糖席夫碱铜基功能材料催化制备β-甲硅烷基氮杂芳烃化合物的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A one pot method for the synthesis of atorvastatin calcium intermediate Effective date of registration: 20220928 Granted publication date: 20210316 Pledgee: Bank of Ningbo Co.,Ltd. Taizhou Branch Pledgor: ZHEJIANG HONGYUAN PHARMACEUTICAL CO.,LTD. Registration number: Y2022330002400 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20201110 Assignee: HENAN YUCHEN PHARMACEUTICAL Co.,Ltd. Assignor: ZHEJIANG HONGYUAN PHARMACEUTICAL CO.,LTD. Contract record no.: X2022330000601 Denomination of invention: A one pot method for the synthesis of atorvastatin calcium intermediate Granted publication date: 20210316 License type: Common License Record date: 20221021 |
|
EE01 | Entry into force of recordation of patent licensing contract |